Data gathered: June 3
Alternative Data for Structure Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 25 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 5,000 | Sign up | Sign up | Sign up |
| Google Trends | 6 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 6 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,282 | Sign up | Sign up | Sign up |
| Twitter Followers | 299 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 157 | Sign up | Sign up | Sign up |
About Structure Therapeutics
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs.
| Price | $21.97 |
| Target Price | Sign up |
| Volume | 786,010 |
| Market Cap | $1.25B |
| Year Range | $14.15 - $43.89 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Universal Beteiligungs und Servicegesellschaft mbH Makes New $3.09 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR)June 3 - ETF Daily News |
 |
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor ConferencesMay 29 - Yahoo |
|
BNP Paribas Financial Markets Takes $304,000 Position in Structure Therapeutics Inc. (NASDAQ:GPCR)May 28 - ETF Daily News |
|
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $78.00 Average Price Target from AnalystsMay 16 - ETF Daily News |
|
What is HC Wainwright’s Estimate for GPCR FY2025 Earnings?May 16 - ETF Daily News |
|
What is Leerink Partnrs’ Forecast for GPCR FY2025 Earnings?May 13 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 0 | 0 | 0 | -47M | -56M | -0.270 |
| Q4 '24 | 0 | 0 | 0 | -36M | -47M | -0.220 |
| Q3 '24 | 0 | 0 | 0 | -34M | -46M | -0.200 |
| Q2 '24 | 0 | 230,000 | -230,000 | -26M | -33M | -0.180 |
| Q1 '24 | 0 | 660,000 | -660,000 | -26M | -32M | -0.190 |
Insider Transactions View All
| FMR LLC filed to sell 1,541,868 shares at $35. March 18 '24 |
| FMR LLC filed to sell 1,563,865 shares at $47.2. February 15 '24 |
Similar companies
Read more about Structure Therapeutics (GPCR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Structure Therapeutics?
The Market Cap of Structure Therapeutics is $1.25B.
What is the current stock price of Structure Therapeutics?
Currently, the price of one share of Structure Therapeutics stock is $21.97.
How can I analyze the GPCR stock price chart for investment decisions?
The GPCR stock price chart above provides a comprehensive visual representation of Structure Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Structure Therapeutics shares. Our platform offers an up-to-date GPCR stock price chart, along with technical data analysis and alternative data insights.
Does GPCR offer dividends to its shareholders?
As of our latest update, Structure Therapeutics (GPCR) does not offer dividends to its shareholders. Investors interested in Structure Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Structure Therapeutics?
Some of the similar stocks of Structure Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.